KPV

History

Interest in KPV originated from studies examining the biological activity of α-MSH, a naturally occurring melanocortin peptide recognized for its role in immune modulation. Researchers discovered that the C-terminal Lys-Pro-Val sequence retained measurable biological activity in several experimental systems despite representing only three amino acids of the parent peptide. Subsequent research focused on evaluating KPV independently, particularly within models of inflammatory bowel disease, skin inflammation, epithelial barrier integrity, and innate immune signaling. Its relatively small molecular size has also made it an attractive candidate for formulation and delivery research.

KPV Structure

Research Findings

KPV is widely investigated for its potential interactions with inflammatory pathways involved in innate immune responses. Experimental studies suggest the peptide may influence cytokine production, NF-κB signaling, epithelial barrier maintenance, and leukocyte activity under laboratory conditions. Current evidence remains primarily preclinical, with research spanning cell culture and animal models. Ongoing investigations continue to evaluate the molecular mechanisms through which KPV may regulate inflammatory responses and tissue homeostasis.

Key areas of research:

• Inflammation Research
• Gastrointestinal Research
• Dermatology Research
• Immunology Research
• Epithelial Barrier Research
• Pulmonary Research
• Cell Signaling Research

References

• The Anti-inflammatory Peptide KPV Regulates NF-κB Signaling and Intestinal Inflammation
• Alpha-MSH and the Tripeptide KPV in Experimental Models of Inflammatory Disease
• Melanocortin Peptides and Their Role in Immune Regulation

References are provided for research context only and do not constitute medical claims. KPV is sold for laboratory research use only.